ENGN Earnings & Financial Statements
enGene Holdings Inc.
$1.87
-$0.07(-3.61%)
43
Overall
80
Value
41
Tech
10
Quality
Market Cap
$130.01M
Volume
952.87K
52W Range
$1.40 - $12.25
Target Price
$7.31
ENGN earnings and financial statements: enGene Holdings Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ENGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$123.17M | -$62.30M | -$26.06M | -$20.09M | -$20.16M |
| EBITDA | -$113.80M | -$52.04M | -$99.72M | - | - |
| Net income | -$117.30M | -$55.14M | -$99.92M | -$18.35M | -$23.44M |
| EPS (diluted) | $2.29 | $1.46 | $-151.22 | $44.30 | $0.01 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $221.47M | $311.17M | $86.96M | $23.91M | $15.03M |
| Total liabilities | $53.76M | $38.56M | $14.47M | $47.41M | $15.35M |
| Shareholders’ equity | $167.71M | $272.61M | $72.49M | -$23.50M | -$324.0K |
| Cash and equivalents | $50.15M | $173.00M | $81.52M | $20.43M | $11.02M |
| Long-term debt | $21.78M | $23.90M | $9.22M | $21.20M | $3.05M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$99.24M | -$48.28M | -$24.74M | -$17.59M | -$15.98M |
| Capital expenditure | -$1.49M | -$925.0K | -$318.0K | - | - |
| Free cash flow | -$100.72M | -$49.21M | -$25.06M | -$17.75M | -$16.23M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENGN | $1.87 | -3.6% | 952.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |